Direkt zum Inhalt
Merck

04616

Millipore

Salzsäure-Konzentrat, 0.01N

Dissolution Media Concentrate, Dilute to 6L to conform to USP & EP

Synonym(e):

Salzsäure -Lösung

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

Empirische Formel (Hill-System):
HCl
CAS-Nummer:
Molekulargewicht:
36.46
MDL-Nummer:

Dampfdruck

190 mmHg ( 25 °C)

Qualität

Dilute to 6L to conform to USP & EP

Haltbarkeit

limited shelf life, expiry date on the label

Konzentration

0.00990-0.01010 N (after dilution)

bp

100 °C (lit.)

SMILES String

Cl

InChI

1S/ClH/h1H

InChIKey

VEXZGXHMUGYJMC-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Anwendung

Dissolution Media Concentrates have been formulated to allow quick and easy dilution to a working solution. The label on each bottle indicates the volume of concentrate in the bottle and the volume to which it must be diluted to provide a final media solution that meets the applicable pharmacopoeia specifications. The user friendly format is designed so that each bottle is a single use unit. The instructions below illustrate just how easy it is to prepare the media.

1. Prepare a clean, dry mixing vessel of a suitable size, 6L, 10L or 25L.
2. Add purified water to approximately one third of the required volume i.e. 2L, 3L or 8L.
3. Carefully pour the entire contents of the bottle of concentrate into the vessel.
4. Rinse the bottle with purified water and add rinsing′s to the mixing vessel.
5. Add purified water to the required volume.
6. Mix thoroughly.
7. Measure the pH and proceed if within specification.
8. Adjust pH if necessary.

Piktogramme

Corrosion

Signalwort

Warning

H-Sätze

P-Sätze

Gefahreneinstufungen

Met. Corr. 1

Lagerklassenschlüssel

8B - Non-combustible corrosive hazardous materials

WGK

nwg

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Thomas Krohn et al.
European journal of nuclear medicine and molecular imaging, 42(2), 210-214 (2014-09-25)
To determine the frequency of seemingly pathological retroperitoneal uptake in the location of the coeliac ganglia in patients undergoing [(68)Ga]PSMA-HBED PET/CT. The study included 85 men with prostate cancer referred for [(68)Ga]PSMA-HBED PET/CT. The PET/CT scans were evaluated for the
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to
Sandra Donkervoort et al.
Human mutation, 36(1), 48-56 (2014-09-11)
Collagen 6-related dystrophies and myopathies (COL6-RD) are a group of disorders that form a wide phenotypic spectrum, ranging from severe Ullrich congenital muscular dystrophy, intermediate phenotypes, to the milder Bethlem myopathy. Both inter- and intrafamilial variable expressivity are commonly observed.
Ann Brinkmalm et al.
Molecular neurodegeneration, 9, 53-53 (2014-11-25)
Synaptic degeneration is an early pathogenic event in Alzheimer's disease, associated with cognitive impairment and disease progression. Cerebrospinal fluid biomarkers reflecting synaptic integrity would be highly valuable tools to monitor synaptic degeneration directly in patients. We previously showed that synaptic
Robert Goldstein et al.
European journal of nuclear medicine and molecular imaging, 42(2), 288-301 (2014-11-14)
Human epidermal growth factor receptor-2 (HER2) overexpression is a predictor of response to anti-HER2 therapy in breast and gastric cancer. Currently, HER2 status is assessed by tumour biopsy, but this may not be representative of the larger tumour mass or

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.